HendersonM, MacGregorE, SykesN, HotopfM: The use of benzodiazepines in palliative care. Palliat Med, 2006; 20:407–412.
2.
DowellD, HaegerichTM, ChouR: CDC guideline for prescribing opioids for chronic pain–United States, 2016. MMWR Recomm Rep, 2016; 65:1–49.
3.
ReeveE, OngM, WuA, et al.: A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. Eur J Clin Pharmacol, 2017; 73:927–935.
4.
SalonojaM, SalminenM, AarnioP, et al.: One-time counselling decreases the use of benzodiazepines and related drugs among community-dwelling older persons. Age Ageing, 2010; 39:313–319.
5.
TannenbaumC, MartinP, TambylnR, et al.: Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: The EMPOWER cluster randomized trial. JAMA Intern Med, 2014; 174:890–898.
6.
DenisC, FatséasM, LavieE, AuriacombeM: Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. Cochrane Database Syst Rev, 2006; 3:CD005194.
VicensC, BejaranoF, SempereE, et al.: Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: Cluster randomised controlled trial in primary care. Br J Psychiatry, 2014; 204:471–479.
9.
NardiAE, FreireRC, ValençaAM, AmreinR: Tapering clonazepam in patients with panic disorder after at least 3 years of treatment. J Clin Psychopharmacol, 2010; 30:290–293.
10.
VoshaarRC, GorgelsWJ, MolAJ, et al.: Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: Three-condition, randomised controlled trial. Br J Psychiatry, 2003; 182:498–504.
11.
SchweizerE1, RickelsK, CaseWG, GreenblattDJ: Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper. Arch Gen Psychiatry, 1990; 47:908–915.
12.
GriffinCE3rd, KayeAM, BuenoFR, KayeAD: Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J, 2013; 13:214–223.
13.
LaderM: Benzodiazepine harm: How can it be reduced?. Br J Clin Pharmacol, 2014; 77:295–301.
14.
CrockfordD, WhiteW, CampbellB: Gabapentin use in benzodiazepine dependence and detoxification. Can J Psychiatr, 2001; 46:287.
15.
HadleyS, MandelF, SchweizerE: Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: A double-blind, placebo-controlled trial. J Psychopharmacol, 2011; 26:461–470.
16.
AshtonC, RawlinsM, TyrerS: A double-blind placebo-controlled study of buspirone in diazepam withdrawal in chronic benzodiazepine users. Br J Psychiatry, 1990; 157:232–238.
17.
KawasakiS, JacapraroJ, RastegarD. Safety and effectiveness of a fixed-dose phenobarbital protocol for inpatient benzodiazepine detoxification. J Subst Abus Treat, 2012; 43:331–334.
